ABSTRACT
AIMS Data-driven diabetes subgroups were proposed as an alternative to address diabetes heterogeneity. However, changes in trends for these subgroups have not been reported. Here, we analyzed trends of diabetes subgroups, stratified by sex, race, education level, age categories and time since diabetes diagnosis in the U.S.
METHODS We used data from consecutive NHANES cycles spanning the 1988-2018 period. Diabetes subgroups (mild obesity-related [MOD], severe-insulin deficient [SIDD], severe-insulin resistant [SIRD], and mild age-related diabetes [MARD]) were classified using validated self-normalizing neural networks. Severe autoimmune-diabetes (SAID) was assessed for NHANES-III. Prevalence was estimated using examination sample weights considering bi-cyclic changes (BC) to evaluate trends and changes over time.
RESULTS Diabetes prevalence in the US increased from 7.5% (95%CI 7.1-7.9) in 1988-1989 to 13.9% (95%CI 13.4-14.4) in 2016-2018 (BC 1.09%, 95%CI 0.98-1.31, p<0.001). Non-Hispanic Blacks had the highest prevalence. Overall, MOD, MARD, and SIDD had an increase during the studied period. Particularly, Non-Hispanic Blacks had sharp increases in MARD and SIDD, Mexican Americans in SIDD, and non-Hispanic Whites in MARD. Males, subjects with secondary/high school, and adults aged 40-64 years had the highest increase in MOD prevalence. Trends in diabetes subgroups sustained after stratifying time since diabetes diagnosis.
CONCLUSIONS Prevalence of diabetes and its subgroups in the U.S. have increased from 1988-2018. These trends were different across sex, ethnicities, education, and age categories, indicating significant heterogeneity in diabetes within the U.S. Obesity burden, population aging, socioeconomic disparities, and lifestyle aspects could be implicated in the uprising trends of diabetes in the U.S.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research received no specific funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NHANES had the approval of the NCHS Ethics Review Board
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
CONFLICT OF INTERESTS: The authors declare that they have no conflict of interests.
We reanalyzed the data according to reviewers' comments and included a refined analytic sample
Data Availability
All data sources and R code are available for reproducibility of results at: https://github.com/oyaxbell/clusters_nhanes